IL22 and chronic rhinosinusitis with nasal polyps: Among 31–50-year olds, control patients had a significantly lower median concentration of IL-22 than patients with CRSwNP (46.2 (31.3–54.9) vs. 132.8 (90.5–146.8) pg/mL, p < 0.001).